Internal Medicine, Gastroenterology · Beverly Hills, CA
NPI
1801059647
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
9454 Wilshire Blvd Ste 510
Beverly Hills, CA, 90212
Phone (310) 855-5855
Groups this clinician bills Medicare through
Medicare paid, 2024
$729K
11,737 services
Medicare patients, 2024
1,298
Average age 76
Drug cost, 2024
$1.8M
3,487 prescriptions
Company payments, 2025
$3,834
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin Basseri was code 99232 (hospital e&m - subsequent), 4,906 times for 516 patients. In total Benjamin Basseri billed 11,737 services in 51 codes, and Medicare paid $729K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 4,906 | 516 | $66.36 | $326K |
| 88305 Surgical Pathology Examination | Office | 2,185 | 330 | $31.32 | $68K |
| 88313 Surgical Pathology Examination | Office | 1,043 | 256 | $10.01 | $10K |
| 99222 Hospital E&M - Initial | Facility | 625 | 491 | $109.70 | $69K |
| 99214 Office E&M - Established | Office | 618 | 416 | $104.05 | $64K |
| 88342 Immunohistochemistry | Office | 616 | 234 | $29.52 | $18K |
| 43239 Upper GI Endoscopy | Facility | 370 | 351 | $64.46 | $24K |
| 45380 Lower GI Endoscopy - Other | Facility | 243 | 242 | $82.56 | $20K |
| 99204 Office E&M - New | Office | 182 | 182 | $130.73 | $24K |
| 99213 Office E&M - Established | Office | 152 | 135 | $73.12 | $11K |
| 45385 Colonoscopy - Lesion Removal | Facility | 140 | 138 | $196.29 | $27K |
| 45381 Lower GI Endoscopy - Other | Facility | 88 | 86 | $14.94 | $1,315 |
| 99203 Office E&M - New | Office | 76 | 76 | $88.34 | $6,714 |
| 43251 Upper GI Endoscopy | Facility | 65 | 62 | $142.54 | $9,265 |
| 99233 Hospital E&M - Subsequent | Facility | 53 | 27 | $99.93 | $5,296 |
By year: 2022 $883K for 14,454 services; 2023 $857K for 13,763 services; 2024 $729K for 11,737 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 2,185 | 330 | $31.32 | $68K |
| 88313 Surgical Pathology Examination | 1,043 | 256 | $10.01 | $10K |
| 88342 Immunohistochemistry | 616 | 234 | $29.52 | $18K |
| 88312 Surgical Pathology Examination | 30 | 29 | $22.22 | $667 |
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin Basseri prescribed most often to Medicare patients was Pantoprazole Sodium, with 557 prescriptions and refills. In total Benjamin Basseri wrote 3,487 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 557 | 1,205 | 193 | $7,018 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 260 | 260 | 247 | $16K |
| Dexlansoprazole Dr Dexlansoprazole | 251 | 350 | 59 | $56K |
| Linzess Linaclotide | 234 | 320 | 66 | $169K |
| Famotidine Generic | 209 | 433 | 67 | $2,850 |
| Motegrity Prucalopride Succinate | 166 | 210 | 35 | $112K |
| Omeprazole Generic | 150 | 322 | 44 | $1,947 |
| Xifaxan Rifaximin | 147 | 147 | 91 | $350K |
| Creon Lipase/Protease/Amylase | 138 | 174 | 31 | $283K |
| Dicyclomine Hcl Generic | 124 | 140 | 41 | $2,501 |
| Lactulose Generic | 108 | 108 | 75 | $591 |
| Lubiprostone Generic | 66 | 74 | 27 | $7,576 |
| Metronidazole Generic | 62 | 62 | 54 | $380 |
| Sucralfate Generic | 61 | 77 | 21 | $1,750 |
| Rabeprazole Sodium Generic | 57 | 89 | 14 | $1,323 |
Brand drugs: - claims; generic drugs: 2,488 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin Basseri $3,834 ($3,834 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $1,309.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 56 | $1,309 |
| Janssen Biotech, Inc. JNJ | 21 | $532 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 29 | $453 |
| Ardelyx, Inc. ARDX | 11 | $289 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $204 |
| Genzyme Corporation SNY | 5 | $173 |
| Aimmune Therapeutics, Inc. | 5 | $159 |
| QOL Medical, LLC | 8 | $154 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $112 |
| Lilly USA, LLC LLY | 4 | $94.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.